Standard BioTools Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
LAB Nasdaq 3850 www.standardbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Standard BioTools Inc.

Standard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Mar 1st, 2025 1:10 pm
Standard BioTools to Participate in Upcoming Investor Conferences - Feb 27th, 2025 9:01 pm
Q4 2024 Standard BioTools Inc Earnings Call - Feb 27th, 2025 12:09 pm
Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Feb 27th, 2025 7:22 am
Standard BioTools: Q4 Earnings Snapshot - Feb 26th, 2025 11:52 pm
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results - Feb 26th, 2025 9:01 pm
Shareholders in Standard BioTools (NASDAQ:LAB) have lost 66%, as stock drops 10.0% this past week - Feb 26th, 2025 1:36 pm
Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 - Feb 12th, 2025 12:00 pm
Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength? - Jan 14th, 2025 11:08 am
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue - Jan 13th, 2025 12:00 pm
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine - Jan 8th, 2025 12:00 pm
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$56m market cap drop, institutional owners may be forced to take severe actions - Jan 2nd, 2025 11:17 am
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Dec 19th, 2024 1:00 pm
Standard BioTools Appoints Alex Kim as Chief Financial Officer - Nov 7th, 2024 1:00 pm
Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Nov 2nd, 2024 1:06 pm
Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Nov 1st, 2024 11:49 am
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... - Oct 31st, 2024 3:00 pm
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates - Oct 30th, 2024 9:20 pm
Standard BioTools: Q3 Earnings Snapshot - Oct 30th, 2024 8:15 pm
Standard BioTools Reports Third Quarter 2024 Financial Results - Oct 30th, 2024 8:01 pm